Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 7281-7290 Newer>

The Motley Fool March 30, 2011 Brian Orelli	How to Play the Pfizer Breakup (If It Happens) The sum of the parts could be worth more than the whole.
The Motley Fool March 30, 2011 Sean Williams	China Clamps Down on Drug Manufacturers These drug manufacturers could be feeling a pinch from new Chinese price caps.
The Motley Fool March 30, 2011 Brian Orelli	Amgen's Long Shot Comes Up Short Amgen and Takeda Pharmaceutical's motesanib didn't extend overall survival in lung cancer patients when combined with Bristol-Myers Squibb's Taxol and carboplatin.
The Motley Fool March 30, 2011 Brian Orelli	Throw the Book at This Guy Cheng Yi Liang, a chemist for the FDA, was charged by the Securities and Exchange Commission with insider trading, among other allegations.
The Motley Fool March 30, 2011 Brian Orelli	This Share Count Might Need Some Obesity Meds Soon Arena gets some dilutive financing.
The Motley Fool March 29, 2011 Brian Orelli	Much More Than a Generic Lawsuit The Supreme Court will decide generic-drug makers fate.
The Motley Fool March 29, 2011 Brian Orelli	Medtronic's Exciting New Toys The device maker received multiple approvals in less than a week.
The Motley Fool March 29, 2011 Brian Orelli	Partnership Now, Payoff Later ARIAD signs up a partner to develop a companion diagnostic.
The Motley Fool March 28, 2011 Brian Orelli	Investors Jump for Yervoy! The Food and Drug Administration approval of Bristol-Myers Squibb's Yervoy came with some surprising labeling news.
The Motley Fool March 25, 2011 Brian Orelli	Teva:P&G :: Peanut Butter:Chocolate The generic-drug maker and consumer-products company are forming a joint venture to sell over-the-counter medication, with both companies bringing their strengths to the table.
<Older 7281-7290 Newer> Return to current articles.